ID   GTF2I_RAT               Reviewed;         979 AA.
AC   Q5U2Y1; Q80SX4;
DT   22-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 2.
DT   29-MAY-2024, entry version 127.
DE   RecName: Full=General transcription factor II-I;
DE            Short=GTFII-I;
DE            Short=TFII-I;
GN   Name=Gtf2i;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=DA, and E3;
RX   PubMed=12461526; DOI=10.1038/ng1058;
RA   Olofsson P., Holmberg J., Tordsson J., Lu S., Akerstrom B., Holmdahl R.;
RT   "Positional identification of Ncf1 as a gene that regulates arthritis
RT   severity in rats.";
RL   Nat. Genet. 33:25-32(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-228 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Interacts with the basal transcription machinery by
CC       coordinating the formation of a multiprotein complex at the C-FOS
CC       promoter, and linking specific signal responsive activator complexes.
CC       Promotes the formation of stable high-order complexes of SRF and PHOX1
CC       and interacts cooperatively with PHOX1 to promote serum-inducible
CC       transcription of a reporter gene deriven by the C-FOS serum response
CC       element (SRE). Acts as a coregulator for USF1 by binding independently
CC       two promoter elements, a pyrimidine-rich initiator (Inr) and an
CC       upstream E-box (By similarity). Required for the formation of
CC       functional ARID3A DNA-binding complexes and for activation of
CC       immunoglobulin heavy-chain transcription upon B-lymphocyte activation
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer (Potential). Interacts with SRF and PHOX1. Binds a
CC       pyrimidine-rich initiator (Inr) and a recognition site (E-box) for
CC       upstream stimulatory factor 1 (USF1). Associates with the PH domain of
CC       Bruton's tyrosine kinase (BTK) (By similarity). May be a component of a
CC       BHC histone deacetylase complex that contains HDAC1, HDAC2,
CC       HMG20B/BRAF35, KDM1A, RCOR1/CoREST, PHF21A/BHC80, ZMYM2, ZNF217, ZMYM3,
CC       GSE1 and GTF2I. Interacts with BTK and ARID3A (By similarity).
CC       Interacts with isoform beta of PRKG1 (By similarity). {ECO:0000250,
CC       ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Colocalizes with BTK in
CC       the cytoplasm. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q5U2Y1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5U2Y1-2; Sequence=VSP_034698;
CC   -!- PTM: Transiently phosphorylated on tyrosine residues by BTK in response
CC       to B-cell receptor stimulation. Phosphorylation on Tyr-248 and Tyr-379,
CC       and perhaps, on Tyr-484 contributes to BTK-mediated transcriptional
CC       activation (By similarity). {ECO:0000250}.
CC   -!- PTM: Sumoylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the TFII-I family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00484}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF547390; AAO32678.1; -; mRNA.
DR   EMBL; AF547391; AAO32679.1; -; mRNA.
DR   EMBL; BC085815; AAH85815.1; -; mRNA.
DR   RefSeq; NP_001001512.2; NM_001001512.2. [Q5U2Y1-2]
DR   RefSeq; XP_017453850.1; XM_017598361.1.
DR   AlphaFoldDB; Q5U2Y1; -.
DR   SMR; Q5U2Y1; -.
DR   BioGRID; 261874; 2.
DR   IntAct; Q5U2Y1; 1.
DR   STRING; 10116.ENSRNOP00000002020; -.
DR   iPTMnet; Q5U2Y1; -.
DR   PhosphoSitePlus; Q5U2Y1; -.
DR   jPOST; Q5U2Y1; -.
DR   PaxDb; 10116-ENSRNOP00000002020; -.
DR   Ensembl; ENSRNOT00000002020.7; ENSRNOP00000002020.3; ENSRNOG00000001479.10. [Q5U2Y1-1]
DR   Ensembl; ENSRNOT00000040356.6; ENSRNOP00000040835.2; ENSRNOG00000001479.10. [Q5U2Y1-2]
DR   Ensembl; ENSRNOT00055000281; ENSRNOP00055000176; ENSRNOG00055000171. [Q5U2Y1-1]
DR   Ensembl; ENSRNOT00060018510; ENSRNOP00060014396; ENSRNOG00060010888. [Q5U2Y1-1]
DR   Ensembl; ENSRNOT00065001622; ENSRNOP00065001138; ENSRNOG00065001214. [Q5U2Y1-1]
DR   GeneID; 353256; -.
DR   KEGG; rno:353256; -.
DR   UCSC; RGD:727961; rat. [Q5U2Y1-1]
DR   AGR; RGD:727961; -.
DR   CTD; 2969; -.
DR   RGD; 727961; Gtf2i.
DR   eggNOG; ENOG502QWD0; Eukaryota.
DR   GeneTree; ENSGT00940000160349; -.
DR   HOGENOM; CLU_011773_0_0_1; -.
DR   InParanoid; Q5U2Y1; -.
DR   OrthoDB; 5308582at2759; -.
DR   PhylomeDB; Q5U2Y1; -.
DR   PRO; PR:Q5U2Y1; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000001479; Expressed in cerebellum and 19 other cell types or tissues.
DR   ExpressionAtlas; Q5U2Y1; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:InterPro.
DR   Gene3D; 3.90.1460.10; GTF2I-like; 6.
DR   InterPro; IPR004212; GTF2I.
DR   InterPro; IPR036647; GTF2I-like_rpt_sf.
DR   InterPro; IPR016659; TF_II-I.
DR   PANTHER; PTHR46304:SF2; GENERAL TRANSCRIPTION FACTOR II-I; 1.
DR   PANTHER; PTHR46304; GENERAL TRANSCRIPTION FACTOR II-I REPEAT DOMAIN-CONTAINING PROTEIN 1; 1.
DR   Pfam; PF02946; GTF2I; 6.
DR   PIRSF; PIRSF016441; TF_II-I; 1.
DR   SUPFAM; SSF117773; GTF2I-like repeat; 6.
DR   PROSITE; PS51139; GTF2I; 6.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cytoplasm; DNA-binding; Isopeptide bond;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CHAIN           2..979
FT                   /note="General transcription factor II-I"
FT                   /id="PRO_0000343749"
FT   REPEAT          103..197
FT                   /note="GTF2I-like 1"
FT   REPEAT          333..427
FT                   /note="GTF2I-like 2"
FT   REPEAT          438..532
FT                   /note="GTF2I-like 3"
FT   REPEAT          543..637
FT                   /note="GTF2I-like 4"
FT   REPEAT          705..799
FT                   /note="GTF2I-like 5"
FT   REPEAT          840..934
FT                   /note="GTF2I-like 6"
FT   REGION          205..231
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          250..325
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          642..695
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          797..818
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          940..979
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           300..307
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        304..320
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        642..656
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        669..694
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         19
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         103
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         130
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ESZ8"
FT   MOD_RES         210
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         214
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         248
FT                   /note="Phosphotyrosine; by BTK"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         334
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ESZ8"
FT   MOD_RES         379
FT                   /note="Phosphotyrosine; by BTK"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         393
FT                   /note="Phosphoserine; by PKG/PRKG1"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         431
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ESZ8"
FT   MOD_RES         484
FT                   /note="Phosphotyrosine; by BTK"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         498
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         537
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ESZ8"
FT   MOD_RES         539
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         649
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         655
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         696
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ESZ8"
FT   MOD_RES         703
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         765
FT                   /note="Phosphoserine; by PKG/PRKG1"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   MOD_RES         804
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        86
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        92
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        94
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        130
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        140
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        185
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        219
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        221
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        221
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        306
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        324
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        334
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        361
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        416
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        431
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        437
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        469
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        475
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        507
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        542
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        641
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        645
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        651
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        661
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        696
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        797
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        808
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        842
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        845
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        860
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        872
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        972
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   CROSSLNK        972
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P78347"
FT   VAR_SEQ         229..294
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_034698"
FT   MOD_RES         Q5U2Y1-2:228
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   979 AA;  110215 MW;  82D35A08122C210D CRC64;
     MAQVAMSALP AEDEESSESR MVVTFLMSAL ESMCKELAKS KAEVACIAVY ETDVFVVGTE
     RGRAFVNTRK DFQKDFVKYC VEEEEKAAEM HKMKCTTQAN RMSVDAVEIE TLRKTVEDYF
     CFCYGKALGK STVVPVPYEK MLRDQSAVAV QGLPEGVAFK HPEHYDLATL KWILENKAGI
     SFIIKRPFLE PKKHLGGRVM AADADRPMLS PGGSCGPIKV KTEPTEDSGI SLEMAAVTVK
     EESEDPDYYQ YNIQGSHHSS EGNEGAEVEV PAEDSTQHVP SETSEDPEVE VTIEDDDYSP
     PTKRPKSSEP PPPPPVPEPT NAGKRKVREF NFEKWNARIT DLRKQVEELF ERKYAQAIKA
     KGPVTIPYPL FQSHVEDLYV EGLPEGIPFR RPSTYGIPRL ERILLAKERI RFVIKKHELL
     NSTREDLQLD KPASGVKEEW YARITKLRKM VDQLFCKKFA EALGSTEAKA VPYQKFEAYP
     NDLYVEGLPE NIPFRSPSWY GIPRLEKIIQ VGNRIKFVIK RPELLTHSTT EVTQPRTNTP
     VKEDWNVRIT KLRKQVEEIF NLKFAQALGL TEAVKVPYPV FESNPEFLYV EGLPEGIPFR
     SPTWFGIPRL ERIVRGSNKI KFVVKKPELV VSYLPPGMAS KINTKALQSP KRPRSPGSNS
     KVPEIEVTVE GPNNNSPQTS TVRTPTQTNG SNVPFKPRGR EFSFEAWNAK ITDLKQKVEN
     LFNEKCGEAL GLKQAVKVPF ALFESFPEDF YVEGLPEGVP FRRPSTFGIP RLEKILRNKA
     KIKFIIKKPE MFETAIKEST SSKSPPRKTN SSPSVNTTAS GVEDLNIIQV TIPDDDNERL
     SKVEKARQLR EQVNDLFSRK FGEAIGMGFP VKVPYRKITI NPGCVVVDGM PPGVSFKAPS
     YLEISSMRRI LDSAEFIKFT VIRPFPGLVI NNQLVDQNES EGPVIQESAE ASQLEVPATE
     EIKETDGSSQ IKQEPDPTW
//
